230 related articles for article (PubMed ID: 9535882)
1. Vaults are up-regulated in multidrug-resistant cancer cell lines.
Kickhoefer VA; Rajavel KS; Scheffer GL; Dalton WS; Scheper RJ; Rome LH
J Biol Chem; 1998 Apr; 273(15):8971-4. PubMed ID: 9535882
[TBL] [Abstract][Full Text] [Related]
2. The Mr 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines.
Schroeijers AB; Siva AC; Scheffer GL; de Jong MC; Bolick SC; Dukers DF; Slootstra JW; Meloen RH; Wiemer E; Kickhoefer VA; Rome LH; Scheper RJ
Cancer Res; 2000 Feb; 60(4):1104-10. PubMed ID: 10706131
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of vaults may be necessary but not sufficient for multidrug resistance.
Siva AC; Raval-Fernandes S; Stephen AG; LaFemina MJ; Scheper RJ; Kickhoefer VA; Rome LH
Int J Cancer; 2001 Apr; 92(2):195-202. PubMed ID: 11291045
[TBL] [Abstract][Full Text] [Related]
4. Cellular functions of vaults and their involvement in multidrug resistance.
Steiner E; Holzmann K; Elbling L; Micksche M; Berger W
Curr Drug Targets; 2006 Aug; 7(8):923-34. PubMed ID: 16918321
[TBL] [Abstract][Full Text] [Related]
5. Cryoelectron microscopy imaging of recombinant and tissue derived vaults: localization of the MVP N termini and VPARP.
Mikyas Y; Makabi M; Raval-Fernandes S; Harrington L; Kickhoefer VA; Rome LH; Stewart PL
J Mol Biol; 2004 Nov; 344(1):91-105. PubMed ID: 15504404
[TBL] [Abstract][Full Text] [Related]
6. Expression profiles of vault components MVP, TEP1 and vPARP and their correlation to other multidrug resistance proteins in ovarian cancer.
Szaflarski W; Sujka-Kordowska P; Pula B; Jaszczyńska-Nowinka K; Andrzejewska M; Zawierucha P; Dziegiel P; Nowicki M; Ivanov P; Zabel M
Int J Oncol; 2013 Aug; 43(2):513-20. PubMed ID: 23739867
[TBL] [Abstract][Full Text] [Related]
7. Multiple human vault RNAs. Expression and association with the vault complex.
van Zon A; Mossink MH; Schoester M; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
J Biol Chem; 2001 Oct; 276(40):37715-21. PubMed ID: 11479319
[TBL] [Abstract][Full Text] [Related]
8. Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression.
van Zon A; Mossink MH; Schoester M; Scheper RJ; Sonneveld P; Wiemer EA
Cancer Res; 2004 Jul; 64(14):4887-92. PubMed ID: 15256459
[TBL] [Abstract][Full Text] [Related]
9. Analysis of MVP and VPARP promoters indicates a role for chromatin remodeling in the regulation of MVP.
Emre N; Raval-Fernandes S; Kickhoefer VA; Rome LH
Biochim Biophys Acta; 2004 Apr; 1678(1):33-46. PubMed ID: 15093136
[TBL] [Abstract][Full Text] [Related]
10. Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer.
Scheffer GL; Schroeijers AB; Izquierdo MA; Wiemer EA; Scheper RJ
Curr Opin Oncol; 2000 Nov; 12(6):550-6. PubMed ID: 11085454
[TBL] [Abstract][Full Text] [Related]
11. Vaults: a ribonucleoprotein particle involved in drug resistance?
Mossink MH; van Zon A; Scheper RJ; Sonneveld P; Wiemer EA
Oncogene; 2003 Oct; 22(47):7458-67. PubMed ID: 14576851
[TBL] [Abstract][Full Text] [Related]
12. Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line.
Huffman KE; Corey DR
Biochemistry; 2005 Feb; 44(7):2253-61. PubMed ID: 15709737
[TBL] [Abstract][Full Text] [Related]
13. Detection of the Mr 110,000 lung resistance-related protein LRP/MVP with monoclonal antibodies.
Schroeijers AB; Scheffer GL; Reurs AW; Pijnenborg AC; Abbondanza C; Wiemer EA; Scheper RJ
J Histochem Cytochem; 2001 Nov; 49(11):1379-85. PubMed ID: 11668191
[TBL] [Abstract][Full Text] [Related]
14. cDNA cloning and disruption of the major vault protein alpha gene (mvpA) in Dictyostelium discoideum.
Vasu SK; Kedersha NL; Rome LH
J Biol Chem; 1993 Jul; 268(21):15356-60. PubMed ID: 8340365
[TBL] [Abstract][Full Text] [Related]
15. MVP and vaults: a role in the radiation response.
Lara PC; Pruschy M; Zimmermann M; Henríquez-Hernández LA
Radiat Oncol; 2011 Oct; 6():148. PubMed ID: 22040803
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics.
Mossink MH; van Zon A; Fränzel-Luiten E; Schoester M; Kickhoefer VA; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
Cancer Res; 2002 Dec; 62(24):7298-304. PubMed ID: 12499273
[TBL] [Abstract][Full Text] [Related]
17. A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells.
Hu Y; Stephen AG; Cao J; Tanzer LR; Slapak CA; Harrison SD; Devanarayan V; Dantzig AH; Starling JJ; Rome LH; Moore RE
Int J Cancer; 2002 Jan; 97(2):149-56. PubMed ID: 11774257
[TBL] [Abstract][Full Text] [Related]
18. vPARP Adjusts MVP Expression in Drug-resistant Cell Lines in Conjunction with MDR Proteins.
Wojtowicz K; Januchowski R; Nowicki M; Zabel M
Anticancer Res; 2017 Jun; 37(6):3015-3023. PubMed ID: 28551640
[TBL] [Abstract][Full Text] [Related]
19. The genomic sequence of the murine major vault protein and its promoter.
Mossink M; van Zon A; Fränzel-Luiten E; Schoester M; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
Gene; 2002 Jul; 294(1-2):225-32. PubMed ID: 12234684
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of major vault protein during the life cycle of the human parasite Schistosoma mansoni.
Reis EV; Pereira RV; Gomes M; Jannotti-Passos LK; Baba EH; Coelho PM; Mattos AC; Couto FF; Castro-Borges W; Guerra-Sá R
Parasitol Int; 2014 Feb; 63(1):120-6. PubMed ID: 24148287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
